Bluebird Bio Inc.'s Gene Therapy for a Brain-wasting Disease Received Accelerated ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)